Parker Richard
Leeds Liver Unit, St. James's University Hospital, Leeds, United Kingdom.
Curr Opin Gastroenterol. 2020 May;36(3):164-168. doi: 10.1097/MOG.0000000000000627.
This review will describe the natural history of alcohol-related liver disease (ArLD) in light of recent data that have synthesized existing knowledge on this topic and described new research cohorts to improve our understanding of progression and outcomes in ArLD.
ArLD occurs after a threshold of alcohol consumption, but this threshold is lowered by the presence of comorbid factors of which obesity is the most common. The most common stage of ArLD is alcohol-related steatosis: this is associated with a low rate of progression to cirrhosis (3%/year) and nonliver-related morbidity is more likely (4 versus 1%/year). In contrast, alcohol-related steatohepatitis or cirrhosis is more dangerous with higher rates of both nonliver and liver-related mortality. Hepatocellular carcinoma occurs at approximately 3%/year amongst people with ArLD cirrhosis.
These data allow an understanding of ArLD to accurately counsel patients and also to guide public health policies. Awareness of the shortcomings of the available data, highlighted in a recent systematic review, will inform the design of further research in particular to describe the multiple interacting factors that may cause ArLD to regress or progress.
本综述将根据近期数据描述酒精性肝病(ArLD)的自然史,这些数据综合了关于该主题的现有知识,并描述了新的研究队列,以增进我们对ArLD进展和结局的理解。
ArLD在达到一定饮酒阈值后发生,但肥胖等合并症的存在会降低该阈值,肥胖是最常见的合并症。ArLD最常见的阶段是酒精性脂肪变性:其进展为肝硬化的发生率较低(每年3%),且非肝脏相关的发病率更高(每年4%对1%)。相比之下,酒精性脂肪性肝炎或肝硬化则更为危险,非肝脏和肝脏相关的死亡率均更高。在患有ArLD肝硬化的人群中,肝细胞癌的发生率约为每年3%。
这些数据有助于准确地为患者提供咨询,从而理解ArLD,也有助于指导公共卫生政策。最近一项系统综述强调了现有数据的不足之处,这将为进一步研究的设计提供参考,特别是用于描述可能导致ArLD消退或进展的多种相互作用因素。